The results in Supplemental Fig. 5-7 show that DPP9 bound to KEAP1 through its ESGE motif in liver cancer cells, inhibited NRF2 ubiquitination degradation and up-regulated NRF2 protein levels. This evidence concerns the gene DPP9 and liver cancer.